Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects.

marked fall in the association constant for diazepam in the presence of valproic acid: Ka = 8.9 x 104 M-1 (diazepam only); Ka = 4.1 x 104 M-1 (diazepam and valproic acid). The results suggest that diazepam, under the conditions used, has one primary binding site on human serum albumin. This is in agreement with the findings of previous authors (Muller & Wollert, 1973; Kober et al., 1979). The inhibition of diazepam binding by valproic acid has been shown to be competitive since the number of binding sites for diazepam remained unchanged while the affinity of diazepam for these sites was reduced. The disposition kinetics of many drugs can be influenced by changes in plasma protein binding. Diazepam is a drug subject to restrictive elimination by hepatic metabolism and it has been shown that for such drugs the total clearance is directly proportional to the free fraction of the drug (Shand, Mitchell & Oates, 1975). Changes in diazepam free fraction may therefore cause an important alteration in disposition. We thank the National Fund for Research into Crippling Diseases for financial support.

[1]  A. Richens,et al.  Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration. , 1981, British journal of clinical pharmacology.

[2]  E. Perucca,et al.  A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. , 1980, British journal of clinical pharmacology.

[3]  A. Monks,et al.  Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. , 1979, British journal of clinical pharmacology.

[4]  A. Richens,et al.  Overnight urine specimens for the determination of D-glucaric acid excretion in man. , 1979, British journal of clinical pharmacology.

[5]  E. Perucca,et al.  Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients. , 1979, British journal of clinical pharmacology.

[6]  N. Huseby Subcellular localization of gamma-glutamyltransferase activity in guinea pig liver. Effect of phenobarbital on the enzyme activity levels. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[7]  E. Ohnhaus,et al.  Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin , 1979, Clinical pharmacology and therapeutics.

[8]  G. Siest,et al.  Localization of gamma-glutamyltransferase in subcellular fractions of rat and rabbit liver: effect of phenobarbital. , 1979, Biochemical pharmacology.

[9]  I. Sjöholm,et al.  Protein binding of diazepam and digitoxin in uremic and normal serum. , 1979, Biochemical pharmacology.

[10]  K. J. Freundt Production of endogenous D-glucaric acid and oxidative N-demethylation of amidopyrine in man: lack of correlation. , 1979, International journal of clinical pharmacology and biopharmacy.

[11]  E. Perucca Clinical consequences of microsomal enzyme-induction by antiepileptic drugs , 1978 .

[12]  T. Sjödin Circular dichroism studies on the inhibiting effect of oleic acid on the binding of diazepam to human serum albumin. , 1977, Biochemical pharmacology.

[13]  I. Stevenson Factors influencing antipyrine elimination. , 1977, British journal of clinical pharmacology.

[14]  B. Lewis,et al.  Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[15]  E. Sellers,et al.  Plasma Protein Binding of Diazepam and Tolbutamide in Chronic Alcoholics , 1976, Journal of clinical pharmacology.

[16]  T. Inaba,et al.  The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. , 1975, Biochemical pharmacology.

[17]  A. Breckenridge,et al.  CLINICAL IMPLICATIONS OF ENZYME INDUCTION , 1971, Basic life sciences.

[18]  S. Rosalki Gamma-glutamyl transpeptidase. , 1975, Advances in clinical chemistry.

[19]  A. Richens,et al.  Inhibition of phenytoin metabolism by sulthiame in epileptic patients. , 1974, British journal of clinical pharmacology.

[20]  S. Thorgeirsson,et al.  Dose‐dependent enzyme induction , 1973, British journal of pharmacology.

[21]  J. Whitfield,et al.  Changes in Plasma γ-Glutamyl Transpeptidase Activity Associated with Alterations in Drug Metabolism in Man , 1973, British medical journal.

[22]  A. Sanghvi,et al.  Determination of 17-hydroxycorticosteroids with p-hydrazinobenzenesulfonic acid-phosphoric acid. , 1973, Analytical chemistry.

[23]  J. Maxwell,et al.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. , 1971, Lancet.

[24]  G. Szász A kinetic photometric method for serum gamma-glutamyl transpeptidase. , 1969, Clinical chemistry.

[25]  D. Cramp,et al.  The fluorometric assay of triglyceride by a semiautomated method. , 1968, Analytical biochemistry.

[26]  C. A. Marsh,et al.  Metabolism of d-glucuronolactone in mammalian systems. Identification of d-glucaric acid as a normal constituent of urine. , 1963, The Biochemical journal.

[27]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .